PRKAA2 and breast carcinoma: Previous reports indicate that metformin, an AMPK activator down-regulates c-MYC in an AMPK-dependent manner in breast cancer cell lines (43).There are several other reports highlighting the significance of AMPK in cancer chemoprevention (44–50).